FDA Clears Hologic’s Breast Cancer Imaging Technology

Hologic’s 3DQuorum Imaging Technology received 510(k) clearance from the FDA. The technology lowers the number of 3D images needed in reviews of breast cancer.

The technology, powered by Hologic’s artificial intelligence analytics system, reconstructs high resolution 3D data to make six millimeter “SmartSlice” images, helping physicians to more quickly identify areas of interest in breast cancer patients.

Using Hologic’s 3DQuorum, radiologists require only one third of the 3D images they normally require during review, the company said.